Risk-based Monitoring of Clinical Trials: An Integrative Approach.

Agrafiotis, Dimitris K; Lobanov, Victor S; Farnum, Michael A; Yang, Eric; Ciervo, Joseph; Walega, Michael; Baumgart, Adam; Mackey, Aaron J

Agrafiotis, Dimitris K; Lobanov, Victor S; Farnum, Michael A; Yang, Eric; Ciervo, Joseph; Walega, Michael; Baumgart, Adam; Mackey, Aaron J.

Afiliação

Agrafiotis DK; Covance, the Drug Development Division of LabCorp, Princeton, New Jersey. Electronic address: dimitris.agrafiotis@gmail.com.
Lobanov VS; Covance, the Drug Development Division of LabCorp, Princeton, New Jersey.
Farnum MA; Covance, the Drug Development Division of LabCorp, Princeton, New Jersey.
Yang E; Covance, the Drug Development Division of LabCorp, Princeton, New Jersey.
Ciervo J; Covance, the Drug Development Division of LabCorp, Princeton, New Jersey.
Walega M; Covance, the Drug Development Division of LabCorp, Princeton, New Jersey.
Baumgart A; Covance, the Drug Development Division of LabCorp, Princeton, New Jersey.
Mackey AJ; Covance, the Drug Development Division of LabCorp, Princeton, New Jersey.

Clin Ther ; 40(7): 1204-1212, 2018 07.

Article em En | MEDLINE | ID: mdl-30100201

Assuntos

Ensaios Clínicos como Assunto; Confiabilidade dos Dados; Fidelidade a Diretrizes; Humanos; Segurança do Paciente; Risco

Palavras-chave

RBM; Xcellerate; clinical informatics; risk-based monitoring; statistical monitoring

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ensaios Clínicos como Assunto Tipo de estudo: Etiology_studies / Guideline / Risk_factors_studies Limite: Humans Idioma: En Revista: Clin Ther Ano de publicação: 2018 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google